NZNehal Mohamed Zuel-Fakkar

Nehal Mohamed Zuel-Fakkar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nehal Mohamed Zuel-Fakkar has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • A. A. Shehab

    Department of Dermatology and Venereology

    1 shared publication
  • Alaa Abd El-Monem El-Tabakh

    Dermatology and Venereology Department, Ain Shams University, Cairo, Egypt

    1 shared publication
  • D. M. Abdel Hameed

    Department of Parasitology, Faculty of Medicine, Ain Shams University, Cairo, Egypt

    1 shared publication
  • Dalia Mitwalli Ragab

    Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Giza, Egypt

    1 shared publication
  • Dina Marie Abdel-Hameed

    Department of Parasitology, Faculty of Medicine, Ain Shams University, 13 B Kornesh El Neel, Aghkhan, Shobra, Cairo, Egypt

    1 shared publication
  • Dina Mohamed Hamed

    Department of Dermatology; Faculty of Medicine; Ain Shams University; Cairo Egypt

    1 shared publication

Latest Publications

  • Ultrastructure study of hair damage after ultraviolet irradiation

    by Nehal Mohamed Zuel-Fakkar, Ekramy Ahmed El Khateeb, Hala Sobhi Cousha, Dina Mohamed Hamed


  • Study of Blastocystis hominis isolates in urticaria: a case–control study

    by N. M. Zuel-Fakkar, D. M. Abdel Hameed, O. M. Hassanin

    Summary: Blastocystis hominis is a common intestinal parasite, with a prevalence in developing countries of up to 50%. The aim of this study was to investigate the association of this parasite with urticaria by determining the genotypic isotypes in the Egyptian population. In total, 54 patients with urticaria and 50 controls were enrolled in the study. Stool samples were examined and assessed by PCR. The parasite was detected in a significantly higher number (P < 0.001) of the patient group than the control group. There was no significant difference between the patients with acute and those with chronic urticaria (P = 0.2). The amoeboid form was found in 60.6% of Blastocystis-positive patients with urticaria, but in none of the healthy controls. Subtype 3 was the only isolate found in both the patient and control groups. We recommend treatment for Blastocystis-positive patients with urticaria in developing countries. The prevalence is much lower (around 10%) in developed countries, where treatment should only be considered in the absence of other possible causes of urticaria.


  • A study of ApaI and TaqI genotypes of the vitamin D receptor in Egyptian patients with psoriasis

    by N. M. Zuel-Fakkar, M. M. Kamel, M. K. Asaad, M. Z. Mahran, A. A. Shehab

    Vitamin D analogues have been found to be effective in treating the skin lesions of psoriasis. The therapy is thought to work through the vitamin D receptors, resulting in alteration of the proliferation/differentiation balance of the cells. Vitamin D also has an effect on T helper cells, which have a major role in the pathogenesis of psoriasis. There is controversy about the association of vitamin D receptor gene polymorphisms with psoriasis in different populations, and it is a factor that might influence the treatment of these patients. To study vitamin D receptor gene polymorphisms using two restriction enzymes in a group of Egyptian patients with psoriasis. In total, 50 patients with psoriasis were examined using restriction fragment length polymorphism analysis to study ApaI and TaqI genotypes of the vitamin D receptor in a sample of Egyptian patients, and compared with 50 healthy control subjects. We did not find any significant difference in ApaI and TaqI vitamin D receptor gene polymorphisms between patients and controls. There is ethnic variability in vitamin D receptor gene polymorphisms. The lack of significant prevalence of the studied gene polymorphisms in our population suggests that their association with other functionally known gene polymorphism might have a role in the pathogenesis of psoriasis.


  • Association of Blastocystis hominis genetic subtypes with urticaria

    by Dina M. Abdel Hameed, Omayma M. Hassanin, Nehal Mohamed Zuel-Fakkar

    Although intestinal parasites are a possible cause of skin disorders, there are few case reports concerning the role of Blastocystis hominis in urticaria. To clarify this association, we determined the frequency of B. hominis genetic subtype in urticarial patients by stool culture and polymerase chain reaction (PCR) and evaluated the clinical and parasitological recovery of urticarial patients after treatment with metronidazole. Of 54 urticarial patients (group I), 18 (33.3%) were diagnosed as acute urticaria (group IA) and 36 (66.7%) were diagnosed as chronic (group IB). Thirty-three (61.1%) out of 54 urticarial (group I) patients were Blastocystis positive by stool culture and PCR. Out of these 33 patients, 21 were symptomatic and 12 were asymptomatic. The amoeboid form was found in 20 (95.2%) out of 21 symptomatic Blastocystis urticarial patients assuring their pathogenic potential. Of 50 normal control group (group II), four (8%) Blastocystis isolates were found with no amoeboid form. B. hominis subtye 3 was the only detected genotype in both groups. Of 20 symptomatic Blastocystis urticarial patients, 12 (60%) patients recovered symptomatically and parasitologically after one course of metronidazole. Recovery reached 100% on repeating the treatment for a second course with disappearance of the amoeboid form. It was concluded that acute urticaria of unknown etiology and chronic idiopathic urticaria patients who are resistant to the ordinary regimen of urticaria treatment might be examined for infection with B. hominis, in order to prescribe the proper specific anti-protozoan treatment.


  • Comparative study of human papilloma virus in untreated and ultraviolet-treated psoriatic patients

    by Samar Abdallah Mohamed Salem, Nehal Mohamed Zuel Fakkar, Ghada Fathi, Sameh Mostafa Abd El-Reheem, Alaa Abd El-Monem El-Tabakh, Dalia Mitwalli Ragab

    Psoriasis is a proliferative disease, and human papilloma virus (HPV) may be one of the causative factors underlying its pathogenesis. To study whether the presence of the virus in psoriatic patients is due to the proliferative nature of the disease or due to the immunosuppression induced in patients receiving phototherapy. Using a nested polymerase chain reaction, a skin biopsy was taken and examined for HPV expression in 20 untreated psoriatic patients, 20 psoriasis patients under phototherapy [narrow band ultraviolet B (UVB)], 20 psoriasis patients under systemic photochemotherapy (psoralen and UVA), 10 healthy controls, and 10 non-psoriatic patients under UV treatment. The virus detection rate in psoriatic patients under photochemotherapy (60%) was significantly higher (P<0.05) compared with the other groups, while the frequency of the virus in the untreated psoriatic group (0%) was statistically insignificant compared with the normal control group (20%). UV treatment may be an underlying factor predisposing patients with psoriasis to infectivity by HPV together with other factors.